AKT1 and cancer: This finding aligns with a previous report 6 but differs from EV uptake-induced signaling observed in other cancers, where pathways such as VEGF/AKT/eNOS/NO, AKT/mTOR/p70S6K, and NF-κB/β-catenin are engaged 58, 62.